Literature DB >> 2033388

Identification of the porcine paramyxovirus LPMV matrix protein gene: comparative sequence analysis with other paramyxoviruses.

M Berg1, A Sundqvist, J Moreno-López, T Linné.   

Abstract

The complete nucleotide sequence of the gene encoding the matrix protein (M) of the porcine paramyxovirus LPMV has been determined. The gene is 1376 nucleotides long including 5' and 3' non-coding sequences with a protein-coding sequence of 1107 nucleotides. The deduced protein, containing 369 amino acids with a calculated Mr of 41,657, is hydrophobic overall with a net positive charge of +17.5. Comparative sequence analysis revealed high amino acid homology to other paramyxovirus M proteins, with the highest degree of identity (46%) with the human mumps virus. This is strong evidence that the porcine paramyxovirus LPMV is a genuine member of the paramyxovirus genus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033388     DOI: 10.1099/0022-1317-72-5-1045

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Analysis of the fusion protein gene of the porcine rubulavirus LPMV: comparative analysis of paramyxovirus F proteins.

Authors:  M Berg; A C Bergvall; M Svenda; A Sundqvist; J Moreno-López; T Linné
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  The haemagglutinin-neuraminidase glycoprotein of the porcine paramyxovirus LPMV: comparison with other paramyxoviruses revealed the closest relationship to simian virus 5 and mumps virus.

Authors:  A Sundqvist; M Berg; J Moreno-López; T Linné
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  The porcine paramyxovirus LPM specifically recognizes sialyl (alpha 2,3) lactose-containing structures.

Authors:  J Reyes-Leyva; P Hernández-Jáuregui; L F Montaño; E Zenteno
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Molecular characterisation of Porcine rubulavirus (PorPV) isolates from different outbreaks in Mexico.

Authors:  S Cuevas-Romero; J F Rivera-Benítez; A-L Blomström; M Ramliden; E Hernández-Baumgarten; P Hernández-Jáuregui; H Ramírez-Mendoza; M Berg
Journal:  Virus Genes       Date:  2016-01-04       Impact factor: 2.332

5.  Purification and characterization of the hemagglutinin-neuraminidase of Porcine rubulavirus LPMV.

Authors:  J Reyes-Leyva; B Espinosa; G Santos; R Zenteno; J Hernández; V Vallejo; E Zenteno
Journal:  Glycoconj J       Date:  1999-09       Impact factor: 2.916

6.  Establishment and characterisation of a porcine rubulavirus (LPMV) persistent infection in porcine kidney cells.

Authors:  B Hjertner; T Linné; J Moreno-López
Journal:  Acta Vet Scand       Date:  1997       Impact factor: 1.695

7.  La Piedad Michoacán Mexico Virus V protein antagonizes type I interferon response by binding STAT2 protein and preventing STATs nuclear translocation.

Authors:  Giuseppe Pisanelli; Maudry Laurent-Rolle; Balaji Manicassamy; Alan Belicha-Villanueva; Juliet Morrison; Bernardo Lozano-Dubernard; Felipa Castro-Peralta; Giuseppe Iovane; Adolfo García-Sastre
Journal:  Virus Res       Date:  2015-11-03       Impact factor: 3.303

8.  Development of Novel Recombinant Antigens of Nucleoprotein and Matrix Proteins of Porcine orthorubulavirus: Antigenicity and Structural Prediction.

Authors:  Rocío Lara-Romero; José Luis Cerriteño-Sánchez; Susana Mendoza-Elvira; José Bryan García-Cambrón; María Azucena Castañeda-Montes; José Manuel Pérez-Aguilar; Julieta Sandra Cuevas-Romero
Journal:  Viruses       Date:  2022-09-01       Impact factor: 5.818

9.  Molecular and epidemiological studies of Porcine rubulavirus infection - an overview.

Authors:  Julieta Sandra Cuevas-Romero; Anne-Lie Blomström; Mikael Berg
Journal:  Infect Ecol Epidemiol       Date:  2015-11-18

10.  Development of a real-time RT-PCR method for detection of porcine rubulavirus (PoRV-LPMV).

Authors:  Sandra Cuevas-Romero; Anne-Lie Blomström; Arcelia Alvarado; Pablo Hernández-Jauregui; Francisco Rivera-Benitez; Humberto Ramírez-Mendoza; Mikael Berg
Journal:  J Virol Methods       Date:  2013-01-07       Impact factor: 2.014

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.